Acknowledgements
LOBO
Funding for editorial assistance during manuscript development was provided by Britannia Pharmaceuticals Ltd. Editorial assistance was provided by Dr Karen Wolstencroft. Many thanks to the following advisors/contributors for their completion of the apomorphine practical use questionnaires: Andrew Lees, UK; Malcolm Steiger, UK; Marc Vérin, France; Filip Bergquist, Sweden; Friederike Sixel-Döring, Germany; Pedro Garcia-Ruiz, Spain; Simon Lewis, Australia; Regina Katzenschlager, Austria; Patricia Lobo, Portugal; Espen Dietrichs, Norway; Fabrizio Stocchi, Italy; Roongroj Bhidayasiri, Thailand. The questionnaire was also completed by the primary author, Tove Henriksen.